B
Bio-Gene Technology Ltd
ASX:BGT
Bio-Gene Technology Ltd
ASX:BGT
Price:
0.035
AUD
Market Closed
Market Cap:
AU$10.7m
Balance Sheet
Balance Sheet Decomposition
Bio-Gene Technology Ltd
Bio-Gene Technology Ltd
Balance Sheet Decomposition is not available for
Bio-Gene Technology Ltd
Bio-Gene Technology Ltd
Balance Sheet
Bio-Gene Technology Ltd
Bio-Gene Technology Ltd
Currency: AUD
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
0
|
4
|
6
|
4
|
6
|
3
|
2
|
1
|
|
| Cash |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
6
|
3
|
2
|
1
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
4
|
6
|
4
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
2
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
3
|
7
|
5
|
6
|
5
|
7
|
4
|
3
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
N/A
|
4
+310%
|
8
+118%
|
6
-27%
|
7
+18%
|
5
-24%
|
7
+46%
|
4
-47%
|
3
-18%
|
2
-32%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
1
+57%
|
1
+27%
|
1
-19%
|
1
-8%
|
1
+33%
|
1
+37%
|
1
-41%
|
0
-40%
|
1
+42%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
2
|
5
|
12
|
12
|
15
|
15
|
20
|
20
|
22
|
23
|
|
| Retained Earnings |
0
|
1
|
3
|
5
|
7
|
9
|
11
|
14
|
17
|
19
|
21
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
3
+515%
|
7
+137%
|
5
-28%
|
6
+21%
|
4
-29%
|
6
+48%
|
3
-49%
|
3
-13%
|
2
-42%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
N/A
|
4
+310%
|
8
+118%
|
6
-27%
|
7
+18%
|
5
-24%
|
7
+46%
|
4
-47%
|
3
-18%
|
2
-32%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
126
|
126
|
128
|
129
|
151
|
154
|
179
|
178
|
201
|
266
|
|
Switch to:
Switch to:
See Also
Discover More
